The absence of intrarenal ACE protects against hypertension

Journal of Clinical Investigation

Volumn 123, Issue 5, 2013, Pages 2011-2023

  Gonzalez Villalobos, Romer A ^a   Janjoulia, Tea ^a   Fletcher, Nicholas K ^b   Giani, Jorge F ^a   Nguyen, Mien T X ^b   Riquier Brison, Anne D ^b   Seth, Dale M ^c   Fuchs, Sebastien ^a   Eladari, Dominique ^d   Picard, Nicolas ^d   Bachmann, Sebastian ^e   Delpire, Eric ^f   Peti Peterdi, Janos ^b   Navar, L Gabriel ^c   Bernstein, Kenneth E ^a   McDonough, Alicia A ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME METABOLISM; HENLE LOOP; HYPERTENSION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; NEPHRON; NONHUMAN; PRIORITY JOURNAL; SODIUM RETENTION; WATER RETENTION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; HYPERTENSION; KIDNEY; LIVER; LOOP OF HENLE; MALE; MICE; NG-NITROARGININE METHYL ESTER; PEPTIDYL-DIPEPTIDASE A; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, DRUG; RENIN-ANGIOTENSIN SYSTEM; SODIUM; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; SYMPORTERS; TRANSCRIPTION FACTORS; WATER;

EID: 84877114487     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI65460     Document Type: Article

References (56)

1. Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8 suppl B):9-20.
2. Alderman MH, Cohen HW, Sealey JE, Laragh JH. Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens. 2004;17(1):1-7.
3. Gonzalez-Villalobos RA, et al. Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion. J Am Soc Nephrol. 2011;22(3):449-459.
4. Kobori H, et al. Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol. 2007;293(3):F938-F945.
5. Lavoie JL, Lake-Bruse KD, Sigmund CD. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol. 2004; 286(5):F965-F971.
6. Sachetelli S, et al. RAS blockade decreases blood pressure and proteinuria in transgenic mice over-expressing rat angiotensinogen gene in the kidney. Kidney Int. 2006;69(6):1016-1023.
7. Campbell DJ, et al. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension. 2004;43(4):854-859.
8. Shen XZ, et al. Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Am J Pathol. 2007;170(6):2122-2134.
9. Cole J, Quach DL, Sundaram K, Corvol P, Capecchi MR, Bernstein KE. Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. Circ Res. 2002;90(1):87-92.
10. Graciano ML, et al. Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol. 2004;15(7):1805-1815.
11. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-angiotensin system in hypertension. Hypertension. 2011;57(3):355-362.
12. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3(1):7.
13. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension. 1993;21(5):660-666.
14. Gonzalez-Villalobos RA, et al. Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol. 2008;295(3):F772-F779.
15. Gonzalez-Villalobos RA, et al. Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension. 2009;53(2):351-355.
16. Matsusaka T, et al. Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol. 2012;23(7):1181-1189.
17. Hall JE, Guyton AC, Coleman TG, Mizelle HL, Woods LL. Regulation of arterial pressure: role of pressure natriuresis and diuresis. Fed Proc. 1986;45(13):2897-2903.
18. Mitchell KD, Braam B, Navar LG. Hypertens-inogenic mechanisms mediated by renal actions of renin-angiotensin system. Hypertension. 1992; 19(1 suppl):I18-I27.
19. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest. 1999;104(7):R19-R23.
20. Ares GR, Caceres PS, Ortiz PA. Molecular regulation of NKCC2 in the thick ascending limb. Am J Physiol Renal Physiol. 2011;301(6):F1143-F1159.
21. Lee DH, et al. Effects of ACE inhibition and AngII stimulation on renal Na-Cl cotransporter distribution, phosphorylation and membrane complex properties. Am J Physiol Cell Physiol. 2013; 304(2):C147-C163.
22. Moriguchi T, et al. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem. 2005;280(52):42685-42693.
23. Ponce-Coria J, et al. Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proc Natl Acad Sci U S A. 2008; 105(24):8458-8463.
24. - cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci. 2008; 121(pt 5):675-684.
25. - cotransporter in the nervous system: evidence for a scaffolding role of the kinase. J Biol Chem. 2003;278(52):52848-52856.
26. Zhao D, Seth DM, Navar LG. Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice. Hypertension. 2009;54(1):120-126.
27. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science. 1991; 252(5014):1813-1816.
28. Riquier-Brison AD, Leong PK, Pihakaski-Maunsbach K, McDonough AA. Angiotensin II stimulates trafficking of NHE3, NaPi2, and associated proteins into the proximal tubule microvilli. Am J Physiol Renal Physiol. 2010;298(1):F177-F186.
29. Shao W, Seth DM, Navar LG. Augmenation of endogenous Angiotensin II levels in Val5-Ang II infused rats. JIM. 2008;56:344-492.
30. Crowley SD, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A. 2006; 103(47):17985-17990.
31. Kobori H, Harrison-Bernard LM, Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension. 2001;37(5):1329-1335.
32. Modrall JG, et al. Depletion of tissue angiotensin-converting enzyme differentially influences the intrarenal and urinary expression of angiotensin peptides. Hypertension. 2004;43(4):849-853.
33. Nakano D, et al. Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol. 2012;23(11):1847-1856.
34. Ying J, et al. Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens. 2012; 25(6):684-689.
35. Gonzalez-Villalobos RA, et al. Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol. 2010;298(1):F150-F157.
36. Shen XZ, et al. Nontraditional roles of Angiotensin-converting enzyme. Hypertension. 2012;59(4):763-768.
37. Duka I, Kintsurashvili E, Gavras I, Johns C, Bresnahan M, Gavras H. Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension. Circ Res. 2001;88(3):275-281.
38. Alhenc-Gelas F, Baussant T, Hubert C, Soubrier F, Corvol P. The angiotensin converting enzyme in the kidney. J Hypertens Suppl. 1989;7(7):S9-S13.
39. Morita H, Abe C. Negative feedforward control of body fluid homeostasis by hepatorenal reflex. Hypertens Res. 2011;34(8):895-905.
40. Ferrario CM, Varagic J. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am J Physiol Renal Physiol. 2010;298(6):F1297-F1305.
41. San-Cristobal P, et al. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway. Proc Natl Acad Sci U S A. 2009;106(11):4384-4389.
42. van der Lubbe N, et al. Angiotensin II induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter independent of aldosterone. Kidney Int. 2011;79(1):66-76.
43. Gurley SB, et al. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab. 2011;13(4):469-475.
44. Brooks HL, Allred AJ, Beutler KT, Coffman TM, Knepper MA. Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice. Hypertension. 2002;39(2 pt 2):470-473.
45. Mamenko M, Zaika O, Ilatovskaya DV, Staruschenko A, Pochynyuk O. Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone. J Biol Chem. 2012;287(1):660-671.
46. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol. 2002;13(5):1131-1135.
47. Verlander JW, et al. Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin. Am J Physiol Renal Physiol. 2011;301(6):F1314- F1325.
48. Pech V, Kim YH, Weinstein AM, Everett LA, Pham TD, Wall SM. Angiotensin II increases chloride absorption in the cortical collecting duct in mice through a pendrin-dependent mechanism. Am J Physiol Renal Physiol. 2007;292(3):F914- F920.
49. McCormick JA, Ellison DH. The WNKs: atypical protein kinases with pleiotropic actions. Physiol Rev. 2011;91(1):177-219.
50. Soundararajan R, Pearce D, Hughey RP, Kleyman TR. Role of epithelial sodium channels and their regulators in hypertension. J Biol Chem. 2010; 285(40):30363-30369.
51. McCormick JA, et al. A SPAK isoform switch modulates renal salt transport and blood pressure. Cell Metab. 2011;14(3):352-364.
52. Yang SS, et al. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol. 2010;21(11):1868-1877.
53. Lin SH, et al. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome. Proc Natl Acad Sci U S A. 2011;108(42):17538-17543.
54. Liu X, et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet. 2011; 12:104.
55. 2O transporters' abundance along the nephron. Am J Physiol Renal Physiol. 2012;303(1):F92-F104.
56. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-685.